“Medizinische Studien für vulnerable Personen: Medizinethiker Prof. Urban Wiesing”

In Germany, most clinical trials are conducted on adults between the ages of 18 and 70. This leaves out about 40% of the population, the so-called vulnerable groups such as children, adolescents and the elderly. However, these are the groups that need medicines for the most serious diseases. CMFI Principal Investigator Urban Wiesing talks about this in the BR2 podcast "Aktuelle Interviews".

Go to Podcast